Form 4: ANI Pharmaceuticals SVP & CFO Stephen P. Carey Reports Tax Withholding on Vesting Restricted Stock

Stephen P. Carey, SVP & CFO of ANI Pharmaceuticals, reports the withholding of shares for tax purposes related to the vesting of restricted stock.

Summary

• On March 23, 2025, Stephen P. Carey, SVP & CFO of ANI Pharmaceuticals, had 6,210 shares of common stock withheld for tax purposes.
• This was related to the vesting of 13,618 shares of restricted stock, which was previously reported.
• The shares were withheld at a price of $64.26 per share.
• Following the transaction, Carey directly owns 180,863 shares of ANI Pharmaceuticals common stock.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing related to tax withholding on vested stock. It doesn't indicate any significant positive or negative developments for the company, but transparency is generally viewed favorably.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track potential alignment or misalignment of interests between management and shareholders.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it is a routine tax withholding event.
• Shareholders may view insider stock ownership changes as a signal of management's confidence in the company.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stephen P. Carey, ANI Pharmaceuticals, ANIP, SVP & CFO, Restricted Stock, Tax Withholding